Panacea Index Logo

Command Palette

Search for a command to run...

Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors.

Obesity reviews : an official journal of the International Association for the Study of Obesity
November 1, 2012
F L Santos et al. (5 authors)
Journal ArticleMeta-AnalysisReviewSystematic ReviewHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the effects of a low-carbohydrate diet (LCD) on weight loss and cardiovascular risk factors through a systematic review and meta-analysis.

Results Summary

The meta-analysis found that LCD significantly reduced body weight, BMI, abdominal circumference, blood pressure, triglycerides, fasting glucose, glycated hemoglobin, insulin, and C-reactive protein, while increasing HDL cholesterol. LDL cholesterol and creatinine did not change significantly, and long-term health effects remain unknown.

Population

1,141 obese patients

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (15)
InterventionDirectionEndpointPopulationDosageImpactClaim #
low-carbohydrate diet (LCD)
decrease
body weight
1,141 obese patients
-7.04 kg [95% CI -7.20/-6.88]
significant decreases
#1
low-carbohydrate diet (LCD)
decrease
body mass index
1,141 obese patients
-2.09 kg m(-2) [95% CI -2.15/-2.04]
significant decreases
#2
low-carbohydrate diet (LCD)
decrease
abdominal circumference
1,141 obese patients
-5.74 cm [95% CI -6.07/-5.41]
significant decreases
#3
low-carbohydrate diet (LCD)
decrease
systolic blood pressure
1,141 obese patients
-4.81 mm Hg [95% CI -5.33/-4.29]
significant decreases
#4
low-carbohydrate diet (LCD)
decrease
diastolic blood pressure
1,141 obese patients
-3.10 mm Hg [95% CI -3.45/-2.74]
significant decreases
#5
low-carbohydrate diet (LCD)
decrease
plasma triglycerides
1,141 obese patients
-29.71 mg dL(-1) [95% CI -31.99/-27.44]
significant decreases
#6
low-carbohydrate diet (LCD)
decrease
fasting plasma glucose
1,141 obese patients
-1.05 mg dL(-1) [95% CI -1.67/-0.44]
significant decreases
#7
low-carbohydrate diet (LCD)
decrease
glycated haemoglobin
1,141 obese patients
-0.21% [95% CI -0.24/-0.18]
significant decreases
#8
low-carbohydrate diet (LCD)
decrease
plasma insulin
1,141 obese patients
-2.24 micro IU mL(-1) [95% CI -2.65/-1.82]
significant decreases
#9
low-carbohydrate diet (LCD)
decrease
plasma C-reactive protein
1,141 obese patients
-
significant decreases
#10
low-carbohydrate diet (LCD)
increase
high-density lipoprotein cholesterol
1,141 obese patients
1.73 mg dL(-1) [95%CI 1.44/2.01]
increase
#11
low-carbohydrate diet (LCD)
no change
low-density lipoprotein cholesterol
1,141 obese patients
no significant change
did not change significantly
#12
low-carbohydrate diet (LCD)
no change
creatinine
1,141 obese patients
no significant change
did not change significantly
#13
low-carbohydrate diet (LCD)
decrease
body weight
-
-
favourable effects
#14
low-carbohydrate diet (LCD)
decrease
major cardiovascular risk factors
-
-
favourable effects
#15
Abstract

A systematic review and meta-analysis were carried out to study the effects of low-carbohydrate diet (LCD) on weight loss and cardiovascular risk factors (search performed on PubMed, Cochrane Central Register of Controlled Trials and Scopus databases). A total of 23 reports, corresponding to 17 clinical investigations, were identified as meeting the pre-specified criteria. Meta-analysis carried out on data obtained in 1,141 obese patients, showed the LCD to be associated with significant decreases in body weight (-7.04 kg [95% CI -7.20/-6.88]), body mass index (-2.09 kg m(-2) [95% CI -2.15/-2.04]), abdominal circumference (-5.74 cm [95% CI -6.07/-5.41]), systolic blood pressure (-4.81 mm Hg [95% CI -5.33/-4.29]), diastolic blood pressure (-3.10 mm Hg [95% CI -3.45/-2.74]), plasma triglycerides (-29.71 mg dL(-1) [95% CI -31.99/-27.44]), fasting plasma glucose (-1.05 mg dL(-1) [95% CI -1.67/-0.44]), glycated haemoglobin (-0.21% [95% CI -0.24/-0.18]), plasma insulin (-2.24 micro IU mL(-1) [95% CI -2.65/-1.82]) and plasma C-reactive protein, as well as an increase in high-density lipoprotein cholesterol (1.73 mg dL(-1) [95%CI 1.44/2.01]). Low-density lipoprotein cholesterol and creatinine did not change significantly, whereas limited data exist concerning plasma uric acid. LCD was shown to have favourable effects on body weight and major cardiovascular risk factors; however the effects on long-term health are unknown.

Medical Subject Headings (MeSH)
Blood GlucoseBlood PressureCardiovascular DiseasesCholesterolDiet, Carbohydrate-RestrictedDietary CarbohydratesHumansInsulinRandomized Controlled Trials as TopicRisk FactorsTreatment OutcomeTriglyceridesWeight Loss
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality80/10
Citation Metrics
Total Citations199
Citations/Year15.3
Relative Citation Ratio6.58
NIH Percentile95.6%
Research Impact Scores
APT Score0.95
Weight Score1.67
Normalized Score0.70
Related Supplements
Systematic review and meta-analysis of clinical trials of th... | Panacea Index